The price of Crossroads shares depends for a large part on successes in monetization of their 972 and non 972 patents. And that depends on litigation and settlement successes. Ultimately this depends on the strength of these patents.
See here for an more high level overview from 2012.
I will post my findings in the comments below. Feel free to do the same.
Disclosure: The author is long CRDS.